| (Values in U.S. Thousands) | Sep, 2018 | Sep, 2017 | Sep, 2016 | Sep, 2015 | Sep, 2014 |
| Sales | 210 | 230 | 1,270 | 760 | 0 |
| Sales Growth | -8.70% | -81.89% | +67.11% | unch | -100.00% |
| Net Income | -5,040 | -5,030 | -5,030 | -2,840 | 0 |
| Net Income Growth | -0.20% | unch | -77.11% | unch | +100.00% |
Serve Robotics Inc (SBOT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Stellar Biotechnologies, Inc. is engaged in the development, manufacture and commercialization of keyhole limpet hemocyanin and technologies. The Company's principle products consist of: stellar KLH protein and stellar KLH ELISA Kits. KLH is a component for cancer vaccines and anticipated therapeutic vaccines, including those for lymphoma, sarcoma, small cell lung cancer, Alzheimer's disease, rheumatoid arthritis, lupus and Post Traumatic Stress Disorder chemical dependencies. It operates primarily in the United States, Europe, and Asia. Stellar Biotechnologies, Inc. is headquartered in Port Hueneme, California.